- Home
- SNGX vs GP Comparison
SNGX vs GP Comparison
Compare SNGX & GP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- GP
- Stock Information
- Founded
- SNGX 1987
- GP 2010
- Country
- SNGX United States
- GP Canada
- Employees
- SNGX N/A
- GP N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- GP Construction/Ag Equipment/Trucks
- Sector
- SNGX Health Care
- GP Consumer Discretionary
- Exchange
- SNGX Nasdaq
- GP Nasdaq
- Market Cap
- SNGX 10.1M
- GP 9.4M
- IPO Year
- SNGX 1987
- GP 2020
- Fundamental
- Price
- SNGX $1.64
- GP $3.15
- Analyst Decision
- SNGX Strong Buy
- GP
- Analyst Count
- SNGX 1
- GP 0
- Target Price
- SNGX $6.00
- GP N/A
- AVG Volume (30 Days)
- SNGX 2.9M
- GP 82.1K
- Earning Date
- SNGX 11-07-2025
- GP 11-13-2025
- Dividend Yield
- SNGX N/A
- GP N/A
- EPS Growth
- SNGX N/A
- GP N/A
- EPS
- SNGX N/A
- GP N/A
- Revenue
- SNGX N/A
- GP $18,399,688.00
- Revenue This Year
- SNGX N/A
- GP $81.12
- Revenue Next Year
- SNGX N/A
- GP $91.69
- P/E Ratio
- SNGX N/A
- GP N/A
- Revenue Growth
- SNGX N/A
- GP N/A
- 52 Week Low
- SNGX $1.09
- GP $2.28
- 52 Week High
- SNGX $6.23
- GP $18.50
- Technical
- Relative Strength Index (RSI)
- SNGX 41.70
- GP 63.40
- Support Level
- SNGX $1.60
- GP $2.87
- Resistance Level
- SNGX $1.97
- GP $3.16
- Average True Range (ATR)
- SNGX 0.16
- GP 0.20
- MACD
- SNGX 0.06
- GP -0.12
- Stochastic Oscillator
- SNGX 61.63
- GP 35.00
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About GP GreenPower Motor Company Inc.
GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.